Kornitzer Capital Management Inc Eli Lilly & CO Transaction History

Kornitzer Capital Management Inc

$5.21 Billion
Q3 2024

A detailed history of Kornitzer Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 129,940 shares of LLY stock, worth $99.8 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

129,940

Previous 132,200 1.71%

Holding current value

$99.8 Million

Previous $120 Million 3.82%

% of portfolio

2.21%

Previous 2.35%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $1.75 Million - $2.17 Million	-2,260 Reduced 1.71%	129,940 $115 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $3.77 Million - $4.72 Million	-5,197 Reduced 3.78%	132,200 $120 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $6.26 Million - $8.37 Million	-10,570 Reduced 7.14%	137,397 $107 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $2.72 Million - $3.21 Million	-5,187 Reduced 3.39%	147,967 $86.3 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $601,624 - $829,431	-1,384 Reduced 0.9%	153,154 $82.3 Million
Q2 2023 Aug 01, 2023	SELL	$350.74 - $468.98 $2.33 Million - $3.11 Million	-6,629 Reduced 4.11%	154,538 $72.5 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $956,740 - $1.12 Million	-3,080 Reduced 1.88%	161,167 $55.3 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $495,187 - $576,991	-1,540 Reduced 0.93%	164,247 $60.1 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $898,334 - $1.02 Million	-3,030 Reduced 1.79%	165,787 $53.6 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $3.33 Million - $3.91 Million	-11,960 Reduced 6.62%	168,817 $54.7 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $614,653 - $763,857	-2,619 Reduced 1.43%	180,777 $51.8 Million
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $1.14 Million - $1.41 Million	-5,057 Reduced 2.68%	183,396 $50.7 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $340,156 - $418,609	-1,535 Reduced 0.81%	188,453 $43.5 Million
Q2 2021 Jul 30, 2021	SELL	$180.55 - $233.54 $1.99 Million - $2.57 Million	-11,005 Reduced 5.48%	189,988 $43.6 Million
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $959,957 - $1.24 Million	-5,842 Reduced 2.82%	200,993 $37.6 Million
Q4 2020 Jan 29, 2021	SELL	$130.46 - $172.63 $156,160 - $206,638	-1,197 Reduced 0.58%	206,835 $34.9 Million
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $1.29 Million - $1.49 Million	-8,835 Reduced 4.07%	208,032 $30.8 Million
Q2 2020 Aug 03, 2020	SELL	$136.42 - $164.18 $3.92 Million - $4.71 Million	-28,718 Reduced 11.69%	216,867 $35.6 Million
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $1.74 Million - $2.15 Million	-14,615 Reduced 5.62%	245,585 $34.1 Million
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $995,425 - $1.23 Million	-9,310 Reduced 3.45%	260,200 $34.2 Million
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $558,511 - $607,516	-5,230 Reduced 1.9%	269,510 $30.1 Million
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $251,493 - $293,556	-2,270 Reduced 0.82%	274,740 $30.4 Million
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $271,039 - $319,033	-2,435 Reduced 0.87%	277,010 $35.9 Million
Q4 2018 Jan 31, 2019	SELL	$105.9 - $118.64 $337,821 - $378,461	-3,190 Reduced 1.13%	279,445 $32.3 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $218,084 - $272,567	-2,540 Reduced 0.89%	282,635 $30.3 Million
Q2 2018 Aug 02, 2018	SELL	$75.7 - $86.88 $134,140 - $153,951	-1,772 Reduced 0.62%	285,175 $24.3 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $32,281 - $38,106	-435 Reduced 0.15%	286,947 $22.2 Million
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $713,287 - $765,082	-8,705 Reduced 2.94%	287,382 $24.3 Million
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $22.8 Million - $25.3 Million	296,087	296,087 $25.3 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Eli Lilly & CO Transaction History